26
|
Aartsen M, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Al Samarai I, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Bagherpour H, Bai X, Barron J, Barwick S, Baum V, Bay R, Beatty J, Becker KH, Tjus J, BenZvi S, Berley D, Bernardini E, Besson D, Binder G, Bindig D, Blaufuss E, Blot S, Bohm C, Boerner M, Bos F, Boeser S, Botner O, Bourbeau E, Bourbeau J, Bradascio F, Braun J, Brenzke M, Bretz HP, Bron S, Brostean-Kaiser J, Burgman A, Busse R, Carver T, Cheng E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin G, Conrad J, Coppin P, Correa P, Cowen D, Cross R, Dave P, Day M, de Andre JPAM, De Clercq C, Delaunay J, Dembinski H, DeRidder S, Desiati P, de Vries K, DeWasseige G, DeWith M, DeYoung T, Díaz-Vélez JC, Di Lorenzo V, Dujmovic H, Dumm J, Dunkman M, Dvorak E, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Evenson P, Fahey S, Fazely A, Felde J, Filimonov K, Finley C, Flis S, Franckowiak A, Friedman E, Fritz A, Gaisser T, Gallagher J, Gerhardt L, Ghorbani K, Glauch T, Gluesenkamp T, Goldschmidt A, Gonzalez J, Grant D, Griffith Z, Haack C, Hallgren A, Halzen F, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill G, Hoffman K, Hoffmann R, Hoinka T, Hokanson-Fasig B, Hoshina K, Huang F, Huber M, Hultqvist K, Huennefeld M, Hussain R, In S, Iovine N, Ishihara A, Jacobi E, Japaridze G, Jeong M, Jero K, Jones B, Kalaczynski P, Kang W, Kappes A, Kappesser D, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley J, Kheirandish A, Kim J, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein S, Koirala R, Kolanoski H, Koepke L, Kopper C, Kopper S, Koschinsky JP, Koskinen J, Kowalski M, Krings K, Kroll M, Krueckl G, Kunwar S, Kurahashi Neilson N, Kuwabara T, Kyriacou A, Labare M, Lanfranchi J, Larson M, Lauber F, Leonard K, Lesiak-Bzdak M, Leuermann M, Liu Q, Lozano Mariscal CJ, Lu L, Luenemann J, Luszczak W, Madsen J, Maggi G, Mahn K, Mancina S, Maruyama R, Mase K, Maunu R, Meagher K, Medici M, Meier M, Menne T, Merino G, Meures T, Miarecki S, Micallef J, Momente G, Montaruli T, Moore R, Morse R, Moulai M, Nahnhauer R, Nakarmi P, Naumann U, Neer G, Niederhausen H, Nowicki S, Nygren D, Pollmann A, Olivas A, Murchadha AÓ, O'Sullivan E, Palczewski T, Pandya H, Pankova D, Peiffer P, Pepper J, de los Heros C, Pieloth D, Pinat E, Plum M, Price B, Przybylski G, Raab C, Raedel L, Rameez M, Rauch L, Rawlins K, Rea IC, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Safa I, Saelzer T, Sanchez S, Sandrock A, Sandroos J, Santander M, Sarkar S, Sarkar S, Satalecka K, Schlunder P, Schmidt T, Schneider A, Schoenen S, Schoneberg S, Schumacher L, Sclanfani S, Seckel D, Seunarine S, Soedingrekso J, Soldin D, Song M, Spiczak G, Spiering C, Stachurska J, Stamatikos M, Stanev T, Stasik A, Stein R, Stettner J, Steuer A, Stezelberger T, Stokstad R, Stoessl A, Strotjohann NL, Stuttard T, Sullivan G, Sutherland M, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tilav S, Toale P, Tobin M, Toennis C, Toscano S, Tosi D, Tselengidou M, Tung C, Turcati A, Turley C, Ty B, Unger L, Usner M, Van Driessche W, Van Eijk D, van Eijndhoven N, Vandenbroucke J, Vanheule S, van Santen J, Vogel E, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandler F, Wandkowsky N, Waza A, Weaver C, Weiss M, Wendt C, Werthebach J, Westerhoff S, Whelan B, Whitehorn N, Wiebe K, Wiebusch C, Wille L, Williams D, Wills L, Wolf M, Wood J, Wood T, Woschnagg K, Xu D, Xu X, Xu Y, Yanez JP, Yodh G, Yoshida S, Yuan T, Abdollahi S, Ajello M, Angioni R, Baldini L, Ballet J, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Berenji B, Bissaldi E, Blandford R, Bonino R, Bottacini E, Bregeon J, Bruel P, Büehler R, Burnett T, Burns E, Buson S, Cameron R, Caputo R, Caraveo PA, Cavazzuti E, Charles E, Chen S, Cheung T, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Conrad J, Costantin D, Cutini S, D'Ammando F, de Palma F, Digel S, Di Lalla N, Di Mauro M, Di Venere L, Domínguez A, Favuzzi C, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giomi M, Giommi P, Giordano F, Giroletti M, Glanzman T, Green D, Grenier I, Grondin MH, Guiriec S, Harding A, Hayashida M, Hays L, Hewitt J, Horan D, Jóhannesson G, Kadler M, Kensei S, Kocevski D, Krauss F, Kreter M, Kuss M, La Mura G, Larsson S, Latronico L, Lemoine-Goumard M, Li J, Longo F, Loparco F, Lovellette M, Lubrano P, Magill J, Maldera S, Malyshev D, Manfreda A, Mazziotta MN, McEnery J, Meyer M, Michelson P, Mizuno T, Monzani ME, Morselli A, Moskalenko I, Negro M, Nuss E, Ojha R, Omodei N, Orienti M, Orlando E, Palatiello M, Paliya V, Perkins J, Persic M, Pesce-Rollins M, Piron F, Porter T, Principe G, Rainò S, Rando R, Rani B, Razzano M, Razzaque S, Reimer A, Reimer O, Renault-Tinacci N, Ritz S, Rochester L, Parkinson PS, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Suson D, Tajima H, Takahashi M, Tanaka Y, Thayer J, Thompson DJ, Tibaldo L, Torres DF, Torresi E, Tosti G, Troja E, Valverde JV, Vianello G, Vogel M, Wood K, Wood M, Zaharijas G, Ahnen ML, Ansoldi S, Antonelli LA, Arcaro C, Baack D, Babić A, Banerjee B, Bangale P, Barres de Almeida U, Barrio JA, González JB, Bednarek W, Bernardini E, Berti A, Bhattacharyya W, Biland A, Blanch O, Bonnoli G, Carosi R, Carosi A, Ceribella G, Chatterjee A, Colak SM, Colin P, Colombo E, Contreras JL, Cortina J, Covino S, Cumani P, Da Vela P, Dazzi F, De Angelis A, De Lotto B, Delfino M, Delgado J, Di Pierro F, Domínguez A, Dominis Prester D, Dorner D, Doro M, Einecke S, Elsaesser D, Fallah Ramazani V, Fernández-Barral A, Fidalgo D, Foffano L, Pfrang K, Fonseca MV, Font L, Fruck C, Galindo D, Gallozzi S, García López RJ, Garczarczyk M, Gaug M, Giammaria P, Godinović N, Gora D, Guberman D, Hadasch D, Hahn A, Hassan T, Hayashida M, Herrera J, Hose J, Hrupec D, Inoue S, Ishio K, Konno Y, Kubo H, Kushida J, Lelas D, Lindfors E, Lombardi S, Longo F, López M, Maggio C, Majumdar P, Makariev M, Maneva G, Manganaro M, Mannheim K, Maraschi L, Mariotti M, Martínez M, Masuda S, Mazin D, Minev M, Miranda JM, Mirzoyan R, Moralejo A, Moreno V, Moretti E, Nagayoshi T, Neustroev V, Niedzwiecki A, Nievas Rosillo M, Nigro C, Nilsson K, Ninci D, Nishijima K, Noda K, Nogués L, Paiano S, Palacio J, Paneque D, Paoletti R, Paredes JM, Pedaletti G, Peresano M, Persic M, Prada Moroni PG, Prandini E, Puljak I, Rodriguez J, Reichardt I, Rhode W, Ribó M, Rico J, Righi C, Rugliancich A, Saito T, Satalecka K, Schweizer T, Sitarek J, Šnidarić I, Sobczynska D, Stamerra A, Strzys M, Surić T, Takahashi M, Tavecchio F, Temnikov P, Terzić T, Teshima M, Torres-Albà N, Treves A, Tsujimoto S, Vanzo G, Vazquez Acosta M, Vovk I, Ward JE, Will M, Zarić D, Franceschini A, Lucarelli F, Tavani M, Piano G, Donnarumma I, Pittori C, Verrecchia F, Barbiellini G, Bulgarelli A, Caraveo P, Cattaneo PW, Colafrancesco S, Costa E, Di Cocco G, Ferrari A, Gianotti F, Giuliani A, Lipari P, Mereghetti S, Morselli A, Pacciani L, Paoletti F, Parmiggiani N, Pellizzoni A, Picozza P, Pilia M, Rappoldi A, Trois A, Vercellone S, Vittorini V, Albert A, Alfaro R, Álvarez C, Arceo R, Arteaga Velázquez JC, Avila Rojas DO, Ayala Solares HA, Becerril AD, Belmont-Moreno E, Bernal A, Caballero Mora KS, Capistrán Rojas T, Carramiñana A, Casanova S, Castillo Maldonado MA, Cotti U, Cotzomi J, Coutiño de León S, De León Acuña CL, De la Fuente E, Hernandez RD, Dichiara S, Dingus B, DuVernois M, Díaz Velez JC, Ellsworth R, Engel K, Fiorino DW, Fleischhack H, Fraija NI, García González JA, Garfias F, González MM, Muñoz AG, Goodman JA, Hampel-Arias Z, Harding JP, Cadena SH, Hona B, Hueyotl-Zahuantitla F, Hui M, Hüntemeyer P, Iriarte A, Jardin-Blicq A, Joshi V, Kaufmann S, Kunde GJ, Lara A, Lauer R, Lee W, Lennarz D, Vargas HL, Linnemann J, Longinotti AL, Luis-Raya G, Luna-García R, Malone K, Marinelli SS, Martinez O, Martinez Castellanos I, Martínez Huerta H, Martínez Castro J, Matthews J, Miranda-Romagnoli P, Moreno Barbosa E, Mostafa M, Nayerhoda A, Nellen L, Newbold M, Nisa MU, Noriega-Papaqui R, Pelayo R, Pretz J, Pérez Pérez EG, Ren Z, Rho CD, Rivière C, González DR, Rosenberg M, Ruiz-Velasco E, Ruiz-Velasco E, Greus FS, Sandoval A, Schneider M, Schoorlemmer H, Sinnis G, Smith AJ, Springer W, Surajbali P, Tibolla O, Tollefson K, Torres I, Villaseñor L, Weisgarber T, Werner F, Yapici T, Yodh G, Zepeda A, Zhou H, Álvarez Romero JDD, Abdalla H, Angüner EO, Armand C, Backes M, Becherini Y, Berge D, Böttcher M, Boisson C, Bolmont J, Bonnefoy S, Bordas P, Brun F, Büchele M, Bulik T, Caroff S, Carosi A, Casanova S, Cerruti M, Chakraborty N, Chandra S, Chen A, Colafrancesco S, Davids ID, Deil C, Devin J, Djannati-Ataï A, Egberts K, Emery G, Eschbach S, Fiasson A, Fontaine G, Funk S, Füßling M, Gallant YA, Gaté F, Giavitto G, Glawion D, Glicenstein JF, Gottschall D, Grondin MH, Haupt M, Henri G, Hinton JA, Hoischen C, Holch TL, Huber D, Jamrozy M, Jankowsky D, Jankowsky F, Jouvin L, Jung-Richardt I, Kerszberg D, Khélifi B, King J, Klepser S, Kluźniak W, Komin N, Kraus M, Lefaucheur J, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Lohse T, López-Coto R, Lorentz M, Lypova I, Marandon V, Martí-Devesa GG, Maurin G, Mitchell A, Moderski R, Mohamed M, Mohrmann L, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Ohm S, Ostrowski M, Oya I, Panter M, Parsons RD, Perennes C, Piel Q, Pita S, Poireau V, Noel AP, Prokoph H, Pühlhofer G, Quirrenbach A, Raab S, Rauth R, Renaud M, Rieger F, Rinchiuso L, Romoli C, Rowell G, Rudak B, Sanchez DA, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Seglar-Arroyo M, Shafi N, Simoni R, Sol H, Stegmann C, Steppa C, Tavernier T, Taylor AM, Tiziani D, Trichard C, Tsirou M, van Eldik C, van Rensburg C, van Soelen B, Veh J, Vincent P, Voisin F, Wagner SJ, Wagner RM, Wierzcholska A, Zanin R, Zdziarski AA, Zech A, Ziegler A, Zorn J, Zywucka N, Savchenko V, Ferrigno C, Bazzano A, Diehl R, Kuulkers E, Laurent P, Mereghetti S, Natalucci L, Panessa F, Rodi J, Ubertini P, Morokuma T, Ohta K, Tanaka YT, Mori H, Yamanaka M, Kawabata KS, Utsumi Y, Nakaoka T, Kawabata M, Nagashima H, Yoshida M, Matsuoka Y, Itoh R, Keel W, Copperwheat C, Steele I, Cenko SB, Evans P, Fox D, Kennea J, Marshall F, Osborne J, Tohuvavohu A, Turley C, Cowen D, DeLaunay J, Keivani A, Santander M, Abeysekara A, Archer A, Benbow W, Bird R, Brill A, Brose R, Buchovecky M, Buckley J, Bugaev V, Christiansen J, Connolly M, Cui W, Daniel M, Errando M, Falcone A, Feng Q, Finley J, Fortson L, Furniss A, Gueta O, Hütten M, Hervet O, Hughes G, Humensky T, Johnson C, Kaaret P, Kar P, Kelley-Hoskins N, Kertzman M, Kieda D, Krause M, Krennrich F, Kumar S, Lang M, Lin T, Maier G, McArthur S, Moriarty P, Mukherjee R, Nieto D, O'Brien S, Ong R, Otte A, Park N, Petrashyk A, Pohl M, Popkow A, Pueschel E, Quinn J, Ragan K, Reynolds P, Richards G, Roache E, Rulten C, Sadeh I, Santander M, Scott S, Sembroski G, Shahinyan K, Sushch I, Trépanier S, Tyler J, Vassiliev V, Wakely S, Weinstein A, Wells R, Wilcox P, Wilhelm A, Williams D, Zitzer B, Tetarenko A, Kimball A, Miller-Jones J, Sivakoff G. Multimessenger observations of a flaring blazar coincident with high-energy neutrino IceCube-170922A. Science 2018; 361:science.aat1378. [DOI: 10.1126/science.aat1378] [Citation(s) in RCA: 451] [Impact Index Per Article: 75.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2018] [Accepted: 06/08/2018] [Indexed: 11/02/2022]
Abstract
Previous detections of individual astrophysical sources of neutrinos are limited to the Sun and the supernova 1987A, whereas the origins of the diffuse flux of high-energy cosmic neutrinos remain unidentified. On 22 September 2017, we detected a high-energy neutrino, IceCube-170922A, with an energy of ~290 tera–electron volts. Its arrival direction was consistent with the location of a known γ-ray blazar, TXS 0506+056, observed to be in a flaring state. An extensive multiwavelength campaign followed, ranging from radio frequencies to γ-rays. These observations characterize the variability and energetics of the blazar and include the detection of TXS 0506+056 in very-high-energy γ-rays. This observation of a neutrino in spatial coincidence with a γ-ray–emitting blazar during an active phase suggests that blazars may be a source of high-energy neutrinos.
Collapse
|
27
|
Dziewanowski K, Myślak M, Drozd R, Krzystolik E, Krzystolik A, Ostrowski M, Droździk M, Tejchman K, Kozdroń K, Sieńko J. Factors Influencing Long-Term Survival of Kidney Grafts Transplanted From Deceased Donors-Analysis Based on a Single-Center Experience. Transplant Proc 2018; 50:1281-1284. [PMID: 29880347 DOI: 10.1016/j.transproceed.2018.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 11/19/2017] [Accepted: 03/01/2018] [Indexed: 10/17/2022]
Abstract
BACKGROUND Kidney transplantation is a routine procedure in the treatment of patients with kidney failure and requires collaboration of experts from different disciplines. Improvements in the procedure result from numerous factors. METHODS The analyzed group consisted of 150 patients divided into 2 equal subgroups: long-term (>15 years) and short-term (<6 years) graft survival. The following factors were taken into consideration: graft survival time, HLA mismatches, recipient sex, sex compatibility, panel reactive antibodies (PRA), cold ischemia time (CIT), and cause of kidney insufficiency. Factors were analyzed in groups with the use of Student t and chi-square tests, Kruskal-Wallis analysis of variance (ANOVA), and multifactorial ANOVA. RESULTS Basic statistical analysis revealed no significance between long-term and short-term survival groups in HLA mismatches, recipient sex, or sex compatibility. There was a very significant difference in CIT. ANOVA revealed no statistical difference between groups in recipient sex, sex compatibility, or recipient disease. There were more patients in the group with long-term survival with lower PRA. There were more women in the group with long-term survival who received kidneys from men. Multifactorial analysis revealed no interactions or independent influence of the selected factors. CONCLUSIONS CIT was a strong independent factor influencing graft survival. Recipient sex and cause of kidney insufficiency seemed to have no impact. Lower PRA was positively correlated with long-term survival. Women who received kidneys from men lived longer with functioning grafts.
Collapse
|
28
|
Abdallah H, Abramowski A, Aharonian F, Ait Benkhali F, Angüner EO, Arakawa M, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bonnefoy S, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Büchele M, Bulik T, Capasso M, Caroff S, Carosi A, Carr J, Casanova S, Cerruti M, Chakraborty N, Chaves RCG, Chen A, Chevalier J, Colafrancesco S, Condon B, Conrad J, Davids ID, Decock J, Deil C, Devin J, deWilt P, Dirson L, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dutson K, Dyks J, Edwards T, Egberts K, Eger P, Emery G, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gallant YA, Garrigoux T, Gaté F, Giavitto G, Giebels B, Glawion D, Glicenstein JF, Gottschall D, Grondin MH, Hahn J, Haupt M, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hinton JA, Hofmann W, Hoischen C, Holch TL, Holler M, Horns D, Ivascenko A, Iwasaki H, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katsuragawa M, Katz U, Kerszberg D, Khangulyan D, Khélifi B, King J, Klepser S, Klochkov D, Kluźniak W, Komin N, Kosack K, Krakau S, Kraus M, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Liu R, Lohse T, Lorentz M, López-Coto R, Lypova I, Malyshev D, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Mohrmann L, Morå K, Moulin E, Murach T, Nakashima S, de Naurois M, Ndiyavala H, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Odaka H, Ohm S, Ostrowski M, Oya I, Padovani M, Panter M, Parsons RD, Pekeur NW, Pelletier G, Perennes C, Petrucci PO, Peyaud B, Piel Q, Pita S, Poireau V, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Rauth R, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Rinchiuso L, Romoli C, Rowell G, Rudak B, Rulten CB, Sahakian V, Saito S, Sanchez DA, Santangelo A, Sasaki M, Schandri M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Seglar-Arroyo M, Settimo M, Seyffert AS, Shafi N, Shilon I, Shiningayamwe K, Simoni R, Sol H, Spanier F, Spir-Jacob M, Stawarz Ł, Steenkamp R, Stegmann C, Steppa C, Sushch I, Takahashi T, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tibaldo L, Tiziani D, Tluczykont M, Trichard C, Tsirou M, Tsuji N, Tuffs R, Uchiyama Y, van der Walt J, van Eldik C, van Rensburg C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zaborov D, Zacharias M, Zanin R, Zdziarski AA, Zech A, Zefi F, Ziegler A, Zorn J, Żywucka N. Search for γ-Ray Line Signals from Dark Matter Annihilations in the Inner Galactic Halo from 10 Years of Observations with H.E.S.S. PHYSICAL REVIEW LETTERS 2018; 120:201101. [PMID: 29864326 DOI: 10.1103/physrevlett.120.201101] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2017] [Revised: 03/05/2018] [Indexed: 06/08/2023]
Abstract
Spectral lines are among the most powerful signatures for dark matter (DM) annihilation searches in very-high-energy γ rays. The central region of the Milky Way halo is one of the most promising targets given its large amount of DM and proximity to Earth. We report on a search for a monoenergetic spectral line from self-annihilations of DM particles in the energy range from 300 GeV to 70 TeV using a two-dimensional maximum likelihood method taking advantage of both the spectral and spatial features of the signal versus background. The analysis makes use of Galactic center observations accumulated over ten years (2004-2014) with the H.E.S.S. array of ground-based Cherenkov telescopes. No significant γ-ray excess above the background is found. We derive upper limits on the annihilation cross section ⟨σv⟩ for monoenergetic DM lines at the level of 4×10^{-28} cm^{3} s^{-1} at 1 TeV, assuming an Einasto DM profile for the Milky Way halo. For a DM mass of 1 TeV, they improve over the previous ones by a factor of 6. The present constraints are the strongest obtained so far for DM particles in the mass range 300 GeV-70 TeV. Ground-based γ-ray observations have reached sufficient sensitivity to explore relevant velocity-averaged cross sections for DM annihilation into two γ-ray photons at the level expected from the thermal relic density for TeV DM particles.
Collapse
|
29
|
Bennett P, Cook L, Betal D, Ostrowski M. Audit of management decision for elderly patients with early breast cancer. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30430-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Marjanski T, Dziedzic R, Ostrowski M, Sledzinska A, Rzyman W. P-095PROLONGED ANTIBIOTIC PROPHYLAXIS REDUCES PERIOPERATIVE RESPIRATORY COMPLICATIONS RATE AFTER CURATIVE RESECTIONS DUE TO LUNG CANCER. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
31
|
Crovesy L, Ostrowski M, Ferreira DMTP, Rosado EL, Soares-Mota M. Effect of Lactobacillus on body weight and body fat in overweight subjects: a systematic review of randomized controlled clinical trials. Int J Obes (Lond) 2017; 41:1607-1614. [PMID: 28792488 DOI: 10.1038/ijo.2017.161] [Citation(s) in RCA: 129] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/03/2017] [Revised: 06/01/2017] [Accepted: 06/25/2017] [Indexed: 12/14/2022]
Abstract
Gut microbiota is important for maintaining body weight. Modulation of gut microbiota by probiotics may result in weight loss and thus help in obesity treatment. The aim of this systematic review was to evaluate the effects of Lactobacillus on weight loss and/or fat mass in overweight adults. A search was performed on the Medline (PubMed) and Scopus electronic databases using the search terms: 'probiotics', 'Lactobacillus, 'obesity', 'body weight changes', 'weight loss', 'overweight', 'abdominal obesity', 'body composition', 'body weight', 'body fat' and 'fat mass'. In the total were found 1567 articles, but only 14 were included in this systematic review. Of these nine showed decreased body weight and/or body fat, three did not find effect and two showed weight gain. Results suggest that the beneficial effects are strain dependent. It can highlight that Lactobacillus plantarum and Lactobacillus rhamnosus when combined with a hypocaloric diet, L. plantarum with Lactobacillus curvatus, Lactobacillus gasseri, Lactobacillus amylovorus, Lactobacillus acidophilus and Lactobacillus casei with phenolic compounds, and multiple species of Lactobacillus.
Collapse
|
32
|
M Kotowski M, Bogacz A, Bartkowiak-Wieczorek J, Sienko J, Procyk D, Dziewanowski K, Ostrowski M, Czerny B, Grzeskowiak E, Machalinski B. The influence of the tumor necrosis factor-alpa-308G>A polymorphism on the efficacy of immunosuppressive therapy in patients after kidney transplantation. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY : AN OFFICIAL JOURNAL OF THE POLISH PHYSIOLOGICAL SOCIETY 2016; 67:819-826. [PMID: 28195062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 10/20/2016] [Accepted: 12/27/2016] [Indexed: 06/06/2023]
Abstract
Cytokines play an important role in the immune response. The calcineurin inhibitors (cyclosporine CsA, tacrolimus TAC) widely used after renal transplantation to prevent allograft rejection are immunosuppressive drugs suppressing the production of cytokines. These drugs are characterized by interindividual variability and require monitoring their blood concentrations to predict their optimal dosage. Therefore, the aim of the study was to determine the correlation between therapeutic effects of immunosuppressants and the tumor necrosis factor-α (TNF-α)-308G>A polymorphism in renal transplant patients. A total of 412 patients receiving TAC and CsA were included in the study. Genotype frequencies were determined using the real-time PCR method. Patients with the GG genotype received higher doses of TAC as compared to carriers of the GA genotype (5.24 mg versus 3.35 mg) and had lower mean drug concentration in blood (5.86 ng/ml versus 6.92 ng/ml). Similar results were also obtained for CsA (GG: 185.33 mg versus GA: 153.30 mg, P < 0.05). The comparison of the TNF-α-308G>A polymorphism with the biochemical parameters did not reveal a potential risk for transplant rejection. These results indicate that the TNF-α-308G>A polymorphism may influence the dosage of immunosuppressive drugs in patients after transplantation as far as individualization of drug therapy is concerned.
Collapse
|
33
|
Ostrowski M, Paulevé L, Schaub T, Siegel A, Guziolowski C. Boolean network identification from perturbation time series data combining dynamics abstraction and logic programming. Biosystems 2016; 149:139-153. [DOI: 10.1016/j.biosystems.2016.07.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2015] [Revised: 07/08/2016] [Accepted: 07/19/2016] [Indexed: 10/21/2022]
|
34
|
Abdalla H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Andersson T, Angüner EO, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RCG, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, Devin J, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Liu R, Lohse T, Lorentz M, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Odaka H, Ohm S, Ostrowski M, Öttl S, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Perennes C, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Settimo M, Seyffert AS, Shafi N, Shilon I, Simoni R, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tibaldo L, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N. H.E.S.S. Limits on Linelike Dark Matter Signatures in the 100 GeV to 2 TeV Energy Range Close to the Galactic Center. PHYSICAL REVIEW LETTERS 2016; 117:151302. [PMID: 27768338 DOI: 10.1103/physrevlett.117.151302] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2016] [Indexed: 06/06/2023]
Abstract
UNLABELLED A search for dark matter linelike signals iss performed in the vicinity of the Galactic Center by the H.E.S.S. experiment on observational data taken in 2014. An unbinned likelihood analysis iss developed to improve the sensitivity to linelike signals. The upgraded analysis along with newer data extend the energy coverage of the previous measurement down to 100 GeV. The 18 h of data collected with the H.E.S.S. array allow one to rule out at 95% C.L. the presence of a 130 GeV line (at l=-1.5°, b=0° and for a dark matter profile centered at this location) previously reported in Fermi-LAT data. This new analysis overlaps significantly in energy with previous Fermi-LAT and H.E.S.S. RESULTS No significant excess associated with dark matter annihilations was found in the energy range of 100 GeV to 2 TeV and upper limits on the gamma-ray flux and the velocity weighted annihilation cross section are derived adopting an Einasto dark matter halo profile. Expected limits for present and future large statistics H.E.S.S. observations are also given.
Collapse
|
35
|
Abdallah H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner E, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RCG, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Lohse T, Lorentz M, Lui R, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Menzler U, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, Odaka H, Ohm S, Öttl S, Ostrowski M, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Seyffert AS, Shafi N, Simoni R, Sol H, Spanier F, Spengler G, Spieß F, Stawarz L, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N. Search for Dark Matter Annihilations towards the Inner Galactic Halo from 10 Years of Observations with H.E.S.S. PHYSICAL REVIEW LETTERS 2016; 117:111301. [PMID: 27661677 DOI: 10.1103/physrevlett.117.111301] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2016] [Indexed: 06/06/2023]
Abstract
The inner region of the Milky Way halo harbors a large amount of dark matter (DM). Given its proximity, it is one of the most promising targets to look for DM. We report on a search for the annihilations of DM particles using γ-ray observations towards the inner 300 pc of the Milky Way, with the H.E.S.S. array of ground-based Cherenkov telescopes. The analysis is based on a 2D maximum likelihood method using Galactic Center (GC) data accumulated by H.E.S.S. over the last 10 years (2004-2014), and does not show any significant γ-ray signal above background. Assuming Einasto and Navarro-Frenk-White DM density profiles at the GC, we derive upper limits on the annihilation cross section ⟨σv⟩. These constraints are the strongest obtained so far in the TeV DM mass range and improve upon previous limits by a factor 5. For the Einasto profile, the constraints reach ⟨σv⟩ values of 6×10^{-26} cm^{3} s^{-1} in the W^{+}W^{-} channel for a DM particle mass of 1.5 TeV, and 2×10^{-26} cm^{3} s^{-1} in the τ^{+}τ^{-} channel for a 1 TeV mass. For the first time, ground-based γ-ray observations have reached sufficient sensitivity to probe ⟨σv⟩ values expected from the thermal relic density for TeV DM particles.
Collapse
|
36
|
Pabisiak K, Ostrowski M, Kram A, Safranow K, Słojewski M, Ciechanowski K. Prostate Specific Antigen–Positive Deceased Organ Donor: A Pathologist Is Indispensable. Transplant Proc 2016; 48:2450-2453. [DOI: 10.1016/j.transproceed.2015.12.142] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2015] [Accepted: 12/30/2015] [Indexed: 10/20/2022]
|
37
|
Sizemore G, Mathur A, Thies K, Bolyard C, Sizemore S, Kladney R, Trimboli A, Kaur B, Leone G, Ostrowski M. Abstract C28: Platelet-derived growth factor receptor-β (PDGFRβ) in the breast metastatic tumor microenvironment. Cancer Res 2016. [DOI: 10.1158/1538-7445.tme16-c28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
A role for the tumor microenvironment (TME) in cancer progression is irrefutable and our laboratory has been at the forefront of this field providing evidence for both tumor suppressive and oncogenic roles of the TME. The PDGF pathway is an exemplar for the study of tumor-stroma interaction as PDGF receptors (PDGFR) are frequently expressed in the fibroblasts and pericytes within the tumor-associated stroma of epithelial tumors including breast cancer. In contrast, PDGF ligands are expressed by the epithelial tumor cells themselves. However, beyond a few descriptive studies, the role of interactive PDGFRβ signaling in the TME during breast cancer initiation, progression and metastases is not understood. This can be attributed in part to limited in vivo models to study the complex TME, especially for breast cancer associated metastases. To overcome this limitation, we have established a transgenic knock-in mouse model that expresses constitutively active PDGFRβ in the stroma of the mammary gland as well in the lung and the brain, two common sites of metastatic breast cancer dissemination. We have found that these mice develop mammary gland hyperplasia highlighting the importance of PDGFRβ in the TME in driving mammary epithelial cell growth. To test whether activation of mutant PDGFRβ in either the lung or the brain increases metastatic growth at either site, two experimental metastases assays were performed: (1) tail vein and (2) intracranial injections to test for lung and brain metastatic outgrowth, respectively. Tail vein injection of the non-metastatic murine mammary cancer cell line DB7 cells led to pronounced lung metastases in PDGFRβ knock-in mice in less than 4 weeks. No macrometastases were seen in the control at this same time point. Similar to the surge in lung metastasis, intracranial injection of DB7 cells led to an increase in tumor growth in brains of the mutant versus wild type controls, revealing an important role for PDGFRβ signaling in the breast cancer metastatic microenvironment. In addition, knockdown of PDGF-B in mammary cancer cells represses intracranial growth in wild type animals. Combined these data support a role for PDGFRβ signaling in the breast cancer metastatic microenvironment. Ongoing investigation is aimed to delineate how activated PDGF-B to PDGFRβ signaling primes the metastatic niche.
Citation Format: Gina Sizemore, Anisha Mathur, Katie Thies, Chelsea Bolyard, Steven Sizemore, Raleigh Kladney, Anthony Trimboli, Balveen Kaur, Gustavo Leone, Michael Ostrowski. Platelet-derived growth factor receptor-β (PDGFRβ) in the breast metastatic tumor microenvironment. [abstract]. In: Proceedings of the AACR Special Conference: Function of Tumor Microenvironment in Cancer Progression; 2016 Jan 7–10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2016;76(15 Suppl):Abstract nr C28.
Collapse
|
38
|
Pabisiak K, Ostrowski M, Kram A, Safranow K, Myślak M, Sieńko J, Sulikowski T, Ciechanowski K. Prostate-Specific Antigen. Transplant Proc 2016; 48:1374-7. [DOI: 10.1016/j.transproceed.2016.01.092] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2015] [Accepted: 01/21/2016] [Indexed: 11/26/2022]
|
39
|
Faure G, Ostrowski M, Saul F. Crystal structure of isoform CBd of the basic PLA2 subunit of crotoxin. Toxicon 2016. [DOI: 10.1016/j.toxicon.2016.01.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
40
|
Paczkowska E, Piecyk K, Luczkowska K, Kotowski M, Roginska D, Pius-Sadowska E, Oronowicz K, Ostrowski M, Machalinski B. Expression of neurotrophins and their receptors in human CD34+ bone marrow cells. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY : AN OFFICIAL JOURNAL OF THE POLISH PHYSIOLOGICAL SOCIETY 2016; 67:151-159. [PMID: 27010904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 09/03/2015] [Accepted: 01/20/2016] [Indexed: 06/05/2023]
Abstract
Bone marrow (BM) CD34+ cells have the ability to secrete growth factors, cytokines, and chemotactic factors. We sought to better characterize this population and to investigate whether human BM CD34+ cells express neurotrophins (NTs) and their relevant receptors. We also compared their expression levels with BM nucleated cells (NCs). BM CD34+ cells were evaluated with respect to the expression levels of neurotrophins using qRT-PCR, immunofluorescent staining, and Western blotting. Next, the expression of specific (TrkA, TrkB, TrkC) and non-specific (p75NTR) neurotrophin receptors was detected by qRT-PCR and immunofluorescent staining in BM CD34+ cells. Using qRT- PCR, we show that even in the absence of inducing factors, CD34+ cells spontaneously express neurotrophins such as NGF, BDNF, NT-3, and NT-4. In addition, the NT expression levels in BM CD34+ cells are considerably higher than in NCs. Furthermore, we confirmed intracellular NT expression in BM CD34+ cells at the protein level using immunofluorescent staining and Western blotting. Using qRT-PCR, we found that immunomagnetically separated BM CD34+ cells spontaneously express high-affinity neurotrophin receptors (TrkA, TrkB, and TrkC) and the low-affinity receptor p75NTR at higher levels than NCs. Immunomagnetic CD34+ cell separation enables for the rapid and gentle sorting of stem/progenitor cells (SPCs) to prepare specific cell types for use in research and clinical applications. Our study suggests that BM CD34+ cells have the potential to support trophic factors for neural tissue and could contribute towards the protection and regeneration of neural cells.
Collapse
|
41
|
Skrobot J, Zair L, Ostrowski M, El Fray M. New injectable elastomeric biomaterials for hernia repair and their biocompatibility. Biomaterials 2016; 75:182-192. [DOI: 10.1016/j.biomaterials.2015.10.037] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2015] [Revised: 10/11/2015] [Accepted: 10/14/2015] [Indexed: 12/22/2022]
|
42
|
Mace T, Shakya R, Pitarresi J, Loftus S, Swanson B, Young G, Zhong X, Zimmers T, Ostrowski M, Ludwig T, Bloomston M, Bekaii-Saab T, Lesinski G. Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. J Immunother Cancer 2015. [PMCID: PMC4649353 DOI: 10.1186/2051-1426-3-s2-p366] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
43
|
Pawlus J, Sierocka A, Tejchman K, Ziętek Z, Romanowski M, Pawlik A, Sieńko J, Żukowski M, Ciechanowski K, Ostrowski M, Sulikowski T. The impact of interleukin 12B (1188A>C), interleukin 16 (-295T>C), and interleukin 18 (607C>A, 137G>C) gene polymorphisms on long-term renal transplant function and recipient outcomes. Transplant Proc 2015; 46:2079-82. [PMID: 25131111 DOI: 10.1016/j.transproceed.2014.06.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Inflammatory mediators play an important role in kidney graft outcome. The cytokine and chemokine gene polymorphisms are associated with variable production, activity, expression, or ligand-receptor affinity. Genetic variation in the DNA sequence of the interleukin 12B (IL12B), interleukin 16 (IL16), and interleukin 18 (IL18) genes may lead to altered cytokine production and activity. These variations can lead to changes in individual patient outcomes after kidney transplantation. It is known that polymorphisms of interleukins have an influence on inflammatory diseases, eg, Crohn's disease, diabetes, and asthma. AIM The aim of this study was to evaluate the correlation between IL12B, IL16, and IL18 gene polymorphisms with delayed graft function (DGF), acute rejection episodes (AR), and chronic rejection episodes (CR). MATERIALS AND METHODS A total of 267 (38.6% women, 61.4% men) recipients were included in the study. Cadaveric kidney transplantations were performed at the Department of General Surgery and Transplantation. Polymerase chain reaction was used to determine gene polymorphisms of IL12B (rs3212227), IL16 (4778889), and IL18 (rs1946518, rs187238) in 2 mL of serum. Statistical significance (P < .05) was analyzed by logit regression, ANOVA and odds ratio (OR) of χ(2) with Yates correction (95% confidence interval). RESULTS Regression analysis revealed no significance between AR/DGF/CR and IL-2B, IL16, IL18rs1946518, and IL18-rs187238 (P > .05). The CR group, AA vs CC genotype of IL18 (rs1946518), had an OR = 2.35 (P = .04). AR and DGF groups had no significance in OR. CONCLUSIONS There was no statistical significance between IL12B, IL16, and IL18 (rs187238) gene polymorphisms and kidney graft outcome after transplantation. Presence of AA genotype (IL18-rs1946518) is connected with a 2.35 times higher risk of CR occurrence.
Collapse
|
44
|
Meisen WH, Dubin S, Sizemore S, Mathsyaraja H, Thies K, Lehman N, Boyer P, Jaime-Ramirez AC, Elder JB, Powell K, Ostrowski M, Kaur B. Abstract P6-16-02: Oncolytic viral therapy enhances the survival of mice in a novel model of breast cancer brain metastases. Cancer Res 2015. [DOI: 10.1158/1538-7445.sabcs14-p6-16-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Breast cancer [BC] is one of the leading causes of brain metastases. The 2 year survival rate of patients with breast cancer brain metastases [BM] is less than 2%. Oncolytic viruses exploit the aberrant molecular and genetic pathways found in cancer cells to selectively replicate in and destroy tumors while sparing normal tissues. Here, we demonstrate the oncolytic Herpes Simplex Virus [HSV-1], 34.5ENVE, can specifically target and destroy BC brain metastases. The 34.5ENVE virus expresses anti-angiogenic Vstat120 and its replication is transcriptionally driven by the cancer specific promoter Nestin. Vstat120 expression is reduced in brain, renal, and gastric cancers, however its expression status in BC is not known. Analysis of The Cancer Genome Atlas revealed a 52% reduction in Vstat120 expression in invasive ductal breast carcinomas [n=69] compared to normal breast tissue [n=389; P<0.0001]. Reduced Vstat120 expression was also associated with decreased disease free survival in BC patients [n=324; P<0.03]. An examination of Vstat120 expression in 50 breast cancer cell lines from the Neve et al dataset showed Vstat120 mRNA levels were reduced in 38% of BC cell lines compared to the MCF-10A epithelial cell line [19 of 50 cell lines]. These analyses suggested BC patients may benefit from the re-expression of anti-angiogenic Vstat120. Nestin is up-regulated in several metastatic cancers, and its expression correlates with reduced survival in BC patients. In a cohort of 166 patients stratified by median Nestin expression, we observed Nestin to be significantly associated with an increased incidence of brain and lung metastases [n=164; P<0.02]. Additional analysis of the Neve et al. microarray dataset showed Nestin was upregulated in 100% of the BC cell lines examined [50 of 50]. These results suggest that Nestin expression may be a strong therapeutic target for BC. 34.5ENVE was cytotoxic to human BC cells of varying subtypes in vitro including the HER2+ and triple negative BCs known to frequently metastasize to the brain. Since 34.5ENVE replication is driven by a Nestin promoter, we compared the cytotoxicity of 34.5ENVE with a similar virus lacking Nestin driven ICP34.5 expression. We observed a 54.14% and 24.44% increase in killing in the MDA-MB-468 and MDA-MB-231 cell lines in the Nestin-driven 34.5ENVE virus as compared to a virus lacking ICP34.5, respectively [P<0.001]. This is the first study to specifically use Nestin expression to target BC. To test the therapeutic efficacy of 34.5ENVE against BM in vivo, we created a novel, immune competent BC BM model using Met-1 and DB-7 murine BC cell lines. Intracranial implantation of these cells resulted in tumors which recapitulated the human BM tumor biology. Treatment of mice with established Met-1 BM tumors with a single, intratumoral dose of 34.5ENVE resulted in significant tumor regression [via MRI] and increased survival. Similarly, mice bearing intracranial DB-7 tumors treated with a single dose of 34.5ENVE showed a doubling of median survival compared to control treated mice [median survival 17 days vs 34 days, respectively; P<0.0004]. The results of these studies warrant further investigation of oncolytic 34.5ENVE viral therapy to treat established BC brain metastases.
Citation Format: W Hans Meisen, Samuel Dubin, Steven Sizemore, Haritha Mathsyaraja, Katie Thies, Norm Lehman, Peter Boyer, Alena C Jaime-Ramirez, J Bradley Elder, Kimerly Powell, Michael Ostrowski, Balveen Kaur. Oncolytic viral therapy enhances the survival of mice in a novel model of breast cancer brain metastases [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P6-16-02.
Collapse
|
45
|
Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner EO, Backes M, Balenderan S, Balzer A, Barnacka A, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Biteau J, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Carrigan S, Casanova S, Chadwick PM, Chakraborty N, Chalme-Calvet R, Chaves RCG, Chrétien M, Colafrancesco S, Cologna G, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Espigat P, Farnier C, Fegan S, Feinstein F, Fernandes MV, Fernandez D, Fiasson A, Fontaine G, Förster A, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Grondin MH, Grudzińska M, Hadasch D, Häffner S, Hahn J, Harris J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hofverberg P, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jahn C, Jamrozy M, Janiak M, Jankowsky F, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kaufmann S, Khélifi B, Kieffer M, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Lohse T, Lopatin A, Lu CC, Marandon V, Marcowith A, Marx R, Maurin G, Maxted N, Mayer M, McComb TJL, Méhault J, Meintjes PJ, Menzler U, Meyer M, Mitchell AMW, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niemiec J, Nolan SJ, Oakes L, Odaka H, Ohm S, Opitz B, Ostrowski M, Oya I, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reichardt I, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwarzburg S, Schwemmer S, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Valerius K, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Völk HJ, Volpe F, Vorster M, Vuillaume T, Wagner SJ, Wagner P, Wagner RM, Ward M, Weidinger M, Weitzel Q, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zechlin HS. Constraints on an annihilation signal from a core of constant dark matter density around the milky way center with H.E.S.S. PHYSICAL REVIEW LETTERS 2015; 114:081301. [PMID: 25768750 DOI: 10.1103/physrevlett.114.081301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2014] [Indexed: 06/04/2023]
Abstract
An annihilation signal of dark matter is searched for from the central region of the Milky Way. Data acquired in dedicated on-off observations of the Galactic center region with H.E.S.S. are analyzed for this purpose. No significant signal is found in a total of ∼9 h of on-off observations. Upper limits on the velocity averaged cross section, ⟨σv⟩, for the annihilation of dark matter particles with masses in the range of ∼300 GeV to ∼10 TeV are derived. In contrast to previous constraints derived from observations of the Galactic center region, the constraints that are derived here apply also under the assumption of a central core of constant dark matter density around the center of the Galaxy. Values of ⟨σv⟩ that are larger than 3×10^{-24} cm^{3}/s are excluded for dark matter particles with masses between ∼1 and ∼4 TeV at 95% C.L. if the radius of the central dark matter density core does not exceed 500 pc. This is the strongest constraint that is derived on ⟨σv⟩ for annihilating TeV mass dark matter without the assumption of a centrally cusped dark matter density distribution in the search region.
Collapse
|
46
|
Nasser MW, Wani NA, Ahirwar DK, Powell CA, Ravi J, Elbaz M, Zhao H, Padilla L, Zhang X, Shilo K, Ostrowski M, Shapiro C, Carson WE, Ganju RK. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Res 2015; 75:974-85. [PMID: 25572331 DOI: 10.1158/0008-5472.can-14-2161] [Citation(s) in RCA: 102] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
RAGE is a multifunctional receptor implicated in diverse processes including inflammation and cancer. In this study, we report that RAGE expression is upregulated widely in aggressive triple-negative breast cancer (TNBC) cells, both in primary tumors and in lymph node metastases. In evaluating the functional contributions of RAGE in breast cancer, we found that RAGE-deficient mice displayed a reduced propensity for breast tumor growth. In an established model of lung metastasis, systemic blockade by injection of a RAGE neutralizing antibody inhibited metastasis development. Mechanistic investigations revealed that RAGE bound to the proinflammatory ligand S100A7 and mediated its ability to activate ERK, NF-κB, and cell migration. In an S100A7 transgenic mouse model of breast cancer (mS100a7a15 mice), administration of either RAGE neutralizing antibody or soluble RAGE was sufficient to inhibit tumor progression and metastasis. In this model, we found that RAGE/S100A7 conditioned the tumor microenvironment by driving the recruitment of MMP9-positive tumor-associated macrophages. Overall, our results highlight RAGE as a candidate biomarker for TNBCs, and they reveal a functional role for RAGE/S100A7 signaling in linking inflammation to aggressive breast cancer development.
Collapse
|
47
|
Ostrowski M, Prochnicki T, Prevost M, Sauguet L, Raynal B, Baron B, Corringer PJ, Faure G. 22. GLIC, a proton-gated ion channel from Gloeobacter violaceus as a new target for phospholipase A2. Toxicon 2014. [DOI: 10.1016/j.toxicon.2014.08.030] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
48
|
Sieńko J, Kotowski MJ, Nowacki A, Romanowski M, Sulikowski T, Ostrowski M. Methylene blue usage in horseshoe kidney graft separation: case report. Transplant Proc 2014; 46:2923-6. [PMID: 25380952 DOI: 10.1016/j.transproceed.2014.09.099] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Definitive diagnostics and strict procedures during kidney donor qualification are required. Nowadays, precise and accurate imaging techniques are at hand for every diagnostician. However, many studies have described intraoperative occurrence of horseshoe kidney. Although the harvesting procedure in the case of horseshoe kidney is not technically difficult, graft separation for successful renal transplantation is a challenge. The complex anatomy of malformed organs causes issues during kidney separation. This procedure may lead to damage of the collecting urinary system as well as vascularization damage. Separate graft transplantation is probable when a thin isthmus in a horseshoe kidney is present. Otherwise, poor graft function may occur. We present a technique for horseshoe kidney separation with the use of methylene blue for vascularization determination. The above-mentioned procedure was performed with the methylene blue solution dose injected into a single renal graft artery. Even with the malformed organ's thick isthmus, the exact incision line was identified, exposing vascular perfusion asymmetry and allowing precise renal graft separation.
Collapse
|
49
|
Mace TA, Pitaressi J, Shakya R, Frankel W, Eubank T, Bekaii-Saab T, Bloomston M, Phelps M, Ludwig T, Ostrowski M, Lesinski GB. Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients. J Immunother Cancer 2013. [PMCID: PMC3990331 DOI: 10.1186/2051-1426-1-s1-p163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
50
|
Ying Z, do Carmo JM, Xiang L, da Silva AA, Chen M, Ryan MJ, Ostrowski M, Rajagopalan S, Hall JE. Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circ Res 2013; 113:562-70. [PMID: 23817200 DOI: 10.1161/circresaha.113.301510] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
RATIONALE Myosin light chain (MLC) phosphorylation determines vascular contractile status. In addition to the classic Ca²⁺-dependent MLC kinase (MLCK), another unidentified kinase(s) also contributes to MLC phosphorylation in living cells. Inhibitor κB kinase 2 (IKK2)-deficient mouse embryonic fibroblasts demonstrate abnormal morphology and migration, suggesting that IKK2 may be involved in MLC phosphorylation. OBJECTIVE Therefore, we tested whether IKK2 is an MLCK in living cells and the role of IKK2 in mediating vasoconstriction and blood pressure regulation. METHODS AND RESULTS In the present study, we showed that recombinant IKK2-phosphorylated MLC and intact myosin in vitro, and the kinetic parameters were comparable with those of the classic MLCK. Overexpression of IKK2 increased cellular MLC phosphorylation level, and pharmacological inhibition of IKK2 markedly decreased vascular smooth muscle cell MLC phosphorylation, suggesting that IKK2 is an MLCK in living cells. IKK2 inhibitors dose- and time-dependently attenuated vasoconstriction elicited by diverse agonists, suggesting the physiological importance of IKK2 as an MLCK. Vascular smooth muscle cell-specific IKK2-deficient mice had decreased aortic contractile responses, and reduced hypertensive responses to several vasoconstrictors, compared with wild-type mice, confirming the physiological importance of IKK2 as an MLCK. CONCLUSIONS Our data provide a novel mechanism whereby IKK2 regulates MLC phosphorylation as an MLCK and, thus, vascular function and blood pressure.
Collapse
|